| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.11 | 0.5 |